Effect of histone deacetylase inhibitors on patient-derived neoadjuvant chemotherapy resistant triple negative breast cancer xenografts that represent understudied patients

Authors

Margarite Matossian, Tulane University
Steven Elliott, Tulane University
Maryl Wright, Tulane University
Tiffany Chang, Tulane University
Madlin Alzoubi, Tulane University
Henri Wathieu, Tulane University
Rachel Sabol, Tulane University
Alex Alfortish, LSU Health Sciences Center - New Orleans
Hope Burks, Tulane University
Van Hoang, Tulane University
Deniz Ucar, LSU Health Sciences Center - New Orleans
Gabrielle Windsor, Tulane University
Thomas Yan, Tulane University
Jovanny Zabaleta, LSU Health Sciences Center - New OrleansFollow
Fokhrul Hossain, LSU Health Sciences Center - New OrleansFollow
Bruce Bunnell, Tulane University
Krzysztof Moroz, Tulane University
Arnold Zea, LSU Health Sciences Center - New OrleansFollow
Adam Riker, LSU Health Sciences Center - New Orleans
Steven Jones, Tulane University

Document Type

Article

Publication Date

2-15-2020

Publication Title

Cancer research

Volume

80(4 Suppl)

Comments

Abstract Number: P6-03-17

Recommended Citation

Matossian, Margarite; Elliott, Steven; Wright, Maryl; Chang, Tiffany; Alzoubi, Madlin; Wathieu, Henri; Sabol, Rachel; Alfortish, Alex; Burks, Hope; Hoang, Van; Ucar, Deniz; Windsor, Gabrielle; Yan, Thomas; Zabaleta, Jovanny; Hossain, Fokhrul; Bunnell, Bruce; Moroz, Krzysztof; Zea, Arnold; Riker, Adam; and Jones, Steven, "Effect of histone deacetylase inhibitors on patient-derived neoadjuvant chemotherapy resistant triple negative breast cancer xenografts that represent understudied patients" (2020). School of Graduate Studies Faculty Publications. 195.
https://digitalscholar.lsuhsc.edu/sogs_facpubs/195
10.1158/1538-7445.SABCS19-P6-03-17